These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25347560)

  • 1. [Treatment of erectile dysfunction after radical prostatectomy should be in accordance with standard regimens].
    Fode M; Hansen RB; Maigaard T; Sønksen J
    Ugeskr Laeger; 2014 Feb; 176(7A):V07130424. PubMed ID: 25347560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of efficacy and satisfaction profile, between penile prosthesis implantation and oral PDE5 inhibitor tadalafil therapy, in men with nerve-sparing radical prostatectomy erectile dysfunction.
    Megas G; Papadopoulos G; Stathouros G; Moschonas D; Gkialas I; Ntoumas K
    BJU Int; 2013 Jul; 112(2):E169-76. PubMed ID: 23253640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal strategy for penile rehabilitation after robot-assisted radical prostatectomy based on preoperative erectile function.
    Basal S; Wambi C; Acikel C; Gupta M; Badani K
    BJU Int; 2013 Apr; 111(4):658-65. PubMed ID: 23186312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penile rehabilitation after radical prostatectomy: what the evidence really says.
    Fode M; Ohl DA; Ralph D; Sønksen J
    BJU Int; 2013 Nov; 112(7):998-1008. PubMed ID: 23826962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of sexual function outcome after radical prostatectomy using phosphodiesterase type 5 inhibitors.
    Kaiho Y; Yamashita S; Arai Y
    Int J Urol; 2013 Mar; 20(3):285-9. PubMed ID: 23311962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment effects of phosphodiesterase-5 inhibitors may improve with time following nerve-sparing radical prostatectomy.
    Fode M; Østergren PB; Jensen CFS; Jakobsen H; Sønksen J
    Scand J Urol; 2018 Apr; 52(2):108-110. PubMed ID: 29057723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT).
    Montorsi F; Brock G; Stolzenburg JU; Mulhall J; Moncada I; Patel HR; Chevallier D; Krajka K; Henneges C; Dickson R; Büttner H
    Eur Urol; 2014 Mar; 65(3):587-96. PubMed ID: 24169081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of vacuum erection devices in penile rehabilitation after radical prostatectomy.
    Lehrfeld T; Lee DI
    Int J Impot Res; 2009; 21(3):158-64. PubMed ID: 19225465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penile Rehabilitation Therapy Following Radical Prostatectomy: A Meta-Analysis.
    Liu C; Lopez DS; Chen M; Wang R
    J Sex Med; 2017 Dec; 14(12):1496-1503. PubMed ID: 29122494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correction of erectile dysfunction in patients undergoing radical prostatectomy].
    Iudovskiĭ SO; Pushkar' DIu
    Urologiia; 2014; (2):66, 68-71. PubMed ID: 24956677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of phosphodiesterase type 5 (PDE5) inhibitors in treating erectile dysfunction after bilateral nerve-sparing radical prostatectomy.
    Cui Y; Liu X; Shi L; Gao Z
    Andrologia; 2016 Feb; 48(1):20-8. PubMed ID: 25684196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of post-prostatectomy erectile dysfunction and a review of the recommended therapeutic modalities.
    Lima TFN; Bitran J; Frech FS; Ramasamy R
    Int J Impot Res; 2021 May; 33(4):401-409. PubMed ID: 33204007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphodiesterase type 5 inhibitors in postprostatectomy erectile dysfunction: a critical analysis of the basic science rationale and clinical application.
    Hatzimouratidis K; Burnett AL; Hatzichristou D; McCullough AR; Montorsi F; Mulhall JP
    Eur Urol; 2009 Feb; 55(2):334-47. PubMed ID: 18986755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention and treatment of erectile dysfunction after prostatectomy: An update].
    Xu P; Wang YH
    Zhonghua Nan Ke Xue; 2017 Jul; 23(7):656-662. PubMed ID: 29723462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of short- and long-term, regular and on-demand regimens of phosphodiesterase type 5 inhibitors in treating erectile dysfunction after nerve-sparing radical prostatectomy: a systematic review and meta-analysis.
    Tian D; Wang XY; Zong HT; Zhang Y
    Clin Interv Aging; 2017; 12():405-412. PubMed ID: 28260869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sildenafil in postprostatectomy erectile dysfunction (perspective).
    Fode M; Jensen CFS; Østergren PB
    Int J Impot Res; 2019 Mar; 31(2):61-64. PubMed ID: 30837719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin promotes erection recovery after nerve-sparing radical retropubic prostatectomy: a retrospective analysis.
    Burnett AL; Allaf ME; Bivalacqua TJ
    J Sex Med; 2008 Oct; 5(10):2392-8. PubMed ID: 18778310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erectile rehabilitation after radical prostatectomy].
    Droupy S; Giuliano F; Costa P;
    Prog Urol; 2009 Dec; 19 Suppl 4():S193-7. PubMed ID: 20123519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of the vacuum erectile device in penile rehabilitation for erectile dysfunction after radical prostatectomy].
    Lin H; Wang G; Wang R
    Zhonghua Nan Ke Xue; 2015 Mar; 21(3):195-9. PubMed ID: 25898548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard operating procedure for the preservation of erectile function outcomes after radical prostatectomy.
    Mulhall JP; Bivalacqua TJ; Becher EF
    J Sex Med; 2013 Jan; 10(1):195-203. PubMed ID: 22970890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.